This study tests a single injection of TG-C into the knee joint for people with moderate knee osteoarthritis. About 535 adults aged 40 and older will receive either TG-C or a placebo and be followed for 2 years. The goal is to see if the treatment improves knee function and reduc…
Phase: PHASE3 • Sponsor: Kolon TissueGene, Inc. • Aim: Disease control
Last updated May 15, 2026 11:57 UTC